Description

CJC-1295 with DAC 

Source: PubChem

CAS Number: 863288-34-0
Molecular Weight: 3647.28 g/mol
Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Gln-Tyr-Gln-Lys-Lys-Gln-Gln-Ser-Gly-Arg-Gly
Formula: C165H269N47O46

Product Overview
CJC-1295 with DAC (Drug Affinity Complex) is a synthetic peptide consisting of 30 amino acids, designed for research on growth hormone-releasing factors (GHRFs). The addition of DAC extends its half-life, making it a subject of interest in studies investigating its potential for stimulating growth hormone release in animal models over prolonged periods.

Key Details:

• Physical Form: Lyophilized powder
• Solubility: Soluble in water
• Purity: ≥98% (by HPLC)
• Storage: Store in a dry, cool place, away from direct sunlight and moisture.

Research Application
CJC-1295 with DAC is widely researched in scientific settings for its ability to stimulate the release of growth hormone in controlled laboratory environments. It is not approved for human consumption or clinical use. Research focuses on its role in promoting growth hormone production and its potential applications in developmental biology and metabolic studies.

Disclaimer:
All products sold by Elite Miami Peptides are intended for laboratory research purposes only. CJC-1295 with DAC is not intended for human use, therapeutic treatment, or clinical application. It is not classified as a prescription drug or supplement, and no health claims are made regarding its use. CJC-1295 with DAC should not be used in humans or animals.

Compliance Notes:
This product is marketed in accordance with advertising policies related to research peptides. No claims are made regarding its use in human health or therapeutic applications. The product does not exploit personal hardships or make misleading health claims. It is intended solely for research purposes.